Loading…
Loading…
Tender Value
Refer Docs
Closing Date
30 Mar 2026, 11:30 amClosed
Single Packet
Normal Tender
No
Not Applicable
Itemwise/Consigneewise
Lowest to Highest
CONSIGNEE
Not Applicable
60 days
Expenditure
General
82
2 conditions · 1 needing a document upload
Procurement will be done only from the PAC (Proprietary Article Certificate) firm or their authorized distributor/agent participating in the tender with the tender specific authorization from the PAC firm
In keeping with the Public Procurement (Preference to Make in India) Order, 2017, as amended, and in terms of clause 2.4.2, 2.4.5 and 2.4.6 of Instructions to Tenderers Rev. 1.21 April 2024 (along with all its correction slips, if any), Public procurement of this item is restricted to Class - I and Class-II local suppliers only. Thus, only class-I and class-II local supplier as defined under the public procurement (Preference to Make in India) Order, 2017, as amended shall be eligible to bid in this tender. Offer from vendors who do not quality to be Class - I (Local Content: minimum 50%) or Class-II (Local Content: minimum 20% but less than 50%) local supplier, shall be summarily rejected and, therefore, such vendors should not participate in the tender. In case any vendor who does not qualify to be a Class - I or Class-II local supplier for the tendered item participates in the tender, such a bidder does so at its own risk and cost and Railways shall not be liable for any loss or damage caused to the bidder on this account . NOTE -: 1- As per Public Procurement (Preference to Make in India) Order, 2017, procurements where the estimated value to be procured is less than Rs 5 lakhs shall be exempt from this Order. 2-Also the drugs which are under GTE relaxation are exempted from this Order.
20 conditions · 2 needing a document upload
NOT APPLICABLE
Firm must mention the name(s) of specific stores of area where such drug is being sold in the open retail market by same brand name.
Firm should mention the detailed address of the manufacturing unit of the tendered item(s). Bidder to upload the outer cartoon of the drug for this purpose.
In terms of clause as per Para 2.4.3 of Instruction to Tenderers regarding restrictions on procurement form a bidder of a country which shares a land border with India. I, hereby confirm that I have read the clause regarding restrictions on procurement form a bidder of a country which shares a land border with India and I certify that I am not from such a country.
Please enter the percentage of local content in the material being offered. Please enter 0 for fully imported items, and 100 for fully indigenous items. The definition and calculation of local content shall be in accordance with the Make in India policy as incorporated in the tender conditions.
Please enter the percentage of local content in the material being offered. Please enter 0 for fully imported items, and 100 for fully indigenous items. The definition and calculation of local content shall be in accordance with the Make in India policy as incorporated in the tender conditions.
1 location across Delhi · 2 Numbers total
2 channels TFT Preconfigured
82265009~NFR
82265009
Limited - Indigenous
Goods
Delhi
₹0
Exempted
30 Mar 2026
24 Mar 2026
1 item · 2 Numbers total
INJ OCRELIZUMAB 300 MG SPECIAL INDENT FOR PATIENT NIBHA MOHANTY [Quantity Tolerance (+/-): 5 %age , Item Category : Normal , Total PO value variation Permitted: Max 8 lacs ] ]
| Delivery Location | State | Quantity |
|---|---|---|
| MD/NRCH/NDLS, NR | Delhi | 2.00 Numbers |
| Total | 2 Numbers | |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
HTML
nit.pdf
NIT
5618788.pdf
ATTACHMENT
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .